Format

Send to

Choose Destination
See comment in PubMed Commons below
Arch Dis Child. 2010 May;95(5):391-2. doi: 10.1136/adc.2009.159210.

Sirolimus and tuberous sclerosis-associated renal angiomyolipomas.

Author information

1
Department of Paediatric Nephrology, Evelina Children's Hospital, Guy's and St Thomas' Hospitals NHS Trust, London, UK.

Abstract

Tuberous sclerosis, caused by germline mutations in the TSC1 or TSC2 genes, is associated with aberrant upregulation of the mammalian target of rapamycin (mTOR) signalling pathway, resulting in growth of tumours, including renal angiomyolipomas (AMLs). AMLs may cause hypertension, renal failure and spontaneous life-threatening haemorrhage. Previously, invasive interventions were required to treat AMLs. More recently, mTOR inhibitors have been used as molecularly targeted treatment to treat AMLs. We present here the case of a paediatric patient with TSC in whom sirolimus has been used successfully to halt growth of renal AMLs.

PMID:
20457704
DOI:
10.1136/adc.2009.159210
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center